Randomized Placebo-Controlled Trial of 2,3-Dimercapto-1-propanesulfonate (DMPS) in Therapy of Chronic Arsenicosis Due to Drinking Arsenic-Contaminated Water

REFERENCES

• Guha Mazumder D. N., Chakraborty A. K., Ghosh A., Gupta J. D., Chakraborty D. P., Dey S. B., Chattopadhyay N. Chronic Arsenic Toxicity from Drinking Tube Well Water in Rural West Bengal. Bull. World Health Organ 1988; 66(4)499–506
   PubMed Web of Science ®Google Scholar
• Guha Mazumder D. N., Das Gupta J., Santra A., Pal A., Ghosh A., Sarkar S. Chronic Arsenic Toxicity in West Bengal: The Worst Calamity in the World. J. Indian Med. Assoc 1998; 96: 4–7
   PubMedGoogle Scholar
• UNICEF. Plan of Action to Combat Situation Arising Out of Arsenic Contamination in Drinking Water: Plan to Assist Govt. of West Bengal. Calcutta. UNICEF, Calcutta. 1998, 5–6
   Google Scholar
• Guha Mazumder D. N., Das Gupta J., Santra A., Pal A., Ghosh A., Sarkar S., Chattopadhyeya N., Chakraborti D. Non-cancer Effects of Chronic Arsenicosis with Special Reference to Liver Damage.In Arsenic: Exposure and Health Effects, C. O. Abernathy, R. L. Calderon, W. R. Chappell. Chapman & Hall, London 1997; 112–123
   Google Scholar
• National Research Council. Arsenic in Drinking Water. National Academy Press, Washington, DC 1999; 130
   Google Scholar
• Arguello R. A., Cenget D., Tello E. E. Cancer and Endemic Arsenism in the Cordoba Region. Rev. Argent. Dermanosifilogr 1938; 22: 461–487
   Google Scholar
• Guha Mazumder D. N., De B. K., Santra A., Dasgupta J., Ghosh N., Roy B. R., Ghossal U. C., Saha J., Chatterjee A., Dutta S., Hague R., Smith A. H., Chakraborti D., Angle C. R., Centeno J. A. Chronic Arsenic Toxicity: Epidemiology, Natural History, and Treatment In Arsenic Exposure and Health Effect, W. R. Chappell, C. O. Abernathy, R. L. Calderon. Elsevier Science Ltd., New York 1999; 335–347
   Google Scholar
• Peters R. A., Stocken L. A., Thompson R. H.S. British Anti-Lewisite (BAL). Nature 1945; 156: 616–619
   PubMed Web of Science ®Google Scholar
• Petrunkin V. E. Synthesis and Properties of Dimercapto Derivatives of Alkylsulfonic Acid. Ukr. Khem. Zh 1956; 22: 603–607
   Google Scholar
• Liang Y. I., Chu C. C., Tsen Y. L., Ting K. S. Studies on Antibilharzial Drugs VI. The Antidotal Effects of Sodium Dimercaptosuccinate and BAL-Glucoside Against Tartar Emetic. Acta Physiol. Sin 1957; 21: 24–32
   Google Scholar
• Inns R. H., Rice P., Bright J. E., Marrs T. C. Evaluation of the Efficacy of Dimercapto Chelating Agents for the Treatment of Systemic Organic Arsenic Poisoning in Rabbits. Hum. Exp. Toxicol 1990; 9: 215–220
   PubMed Web of Science ®Google Scholar
• Inns R. H., Rice P. Efficacy of Dimercapto Chelating Agents for the Treatment of Poisoning by Percutaneously Applied Dichloro (2-Chlorovinyl) Arsine in Rabbits. Hum. Exp. Toxicol 1993; 12: 241–246
   PubMed Web of Science ®Google Scholar
• Kreppel H., Paepcke U., Thiermann H., Szinicz L., Reichl F. X., Singh P. K., Jones M. M. Therapeutic Efficacy of New Dimercaptosuccinic Acid (DMSA) Analogues in Acute Arsenic Trioxide Poisoning in Mice. Arch. Toxicol 1993; 67(8)580–585
   PubMed Web of Science ®Google Scholar
• KreppeL H., Reichl F. X., Szinicz L., Fichtl B., Forth W. Efficacy of Various Dithiol Compounds in Acute Arsenic Poisoning in Mice. Arch. Toxicol 1990; 64: 384–392
   Google Scholar
• Reichl F. X., Kreppel H., Forth W. Pyruvate and Lactate Metabolism in Livers of Guinea Pigs Perfused with Chelating Agents After Repeated Treatment with AS2O3. Arch. Toxicol 1991; 65: 235–238
   PubMed Web of Science ®Google Scholar
• Aposhian H. V., Maiorino R. M., Gonzalex-Ramirez D., Zuniga-Charles M., Xu Z., Hurlbat K. M., Juneo-Munoz P., Dart R. C., Aposhian M. M. Mobilization of Heavy Metals by Newer, Therapeutically Useful Chelating Agents. Toxicology 1995; 97: 23–38
   PubMed Web of Science ®Google Scholar
• Guha Mazumder D. N., Ghoshal U. C., Saha J., Santra A., De B. K., Chatterjee A., Dutta S., Angle C. R., Centeno J. A. Randomized Placebo Controlled Trial of 2,3-Dimercaptosuccinic Acid in Therapy of Chronic Arsenicosis Due to Drinking Arsenic Contaminated Subsoil Water. J. Toxicol. Clin. Toxicol 1998; 36: 683–690
   PubMed Web of Science ®Google Scholar
• Atallah R., Kalman D. A. On-Line Photo-Oxidation for the Determination of Organoarsenic Compounds by Atomic Absorption Spectrometry with Continuous Arsine Generation. Talanta 1991; 38: 167–173
   PubMed Web of Science ®Google Scholar
• Kosnett M. J. Clinical Approaches to the Treatment of Chronic Arsenic Intoxication From Chelation to Chemoprevention. In Arsenic Exposure and Health Effects, W. R. Chappell, C. O. Abernathy, R. L. Caldern. Elsevier Science Ltd., New York 1999; 349–354
   Google Scholar
• Eagle H., Magnuson H. J. The Systemic Treatment of 227 Cases of Arsenic Poisoning (Encephalitis, Dermatitis, Blood Dyscrasias, Jaundice, Fever) with 2,3-Dimercaptopropanol (BAL). Am. J. Syph. Gom. V.D 1946; 30: 420–441
   PubMedGoogle Scholar
• Aposhian H. V., Arroyo A., Cebrian M. E., del Raeo L. M., Hurlbut K. M., Dart R. C., Gonzalez-Ramirez D., Kreppel H., Speisky H., Smith A., Gonsebatt M. E., Ostrosky-Wegman P., Aposhian M. M. DMPS—Arsenic Challenge Test I. Increased Urinary Excretion of Monomethylarsonic Acid in Humans Given Dimercaptopropane Sulfonate. J. Pharmacol. Exp. Ther 1997; 282: 192–200
   PubMed Web of Science ®Google Scholar
• Maiorino R. M., Dart R. C., Carter D. E., Aposhian H. V. Determination and Metabolism of Dithiol Chelating Agent. XII. Metabolism and Pharmacokinetics of Sodium 2,3-Dimercaptopropane-1-sulfonate in Humans. J. Pharmacol. Exp. Ther 1991; 259: 808–814
   PubMed Web of Science ®Google Scholar
• Zheng W., Maiorino R. M., Brendel K., Aposhian H. V. Determination and Metabolism of Dithiol Chelating Agents. VII. Biliary Excretion of Dithiols and Their Interactions with Cadmium and Metallothionein. Fund. Appl. Toxicol 1990; 14: 598–607
   PubMedGoogle Scholar
• Wildenauer D. B., Reuther H., Weger N. Interactions of the Chelating Agent 2,3-Dimercaptopropane-1-sulfonate with Red Blood Cells in Vitro. I. Evidence for Carrier Mediated Transport. Chem. Biol. Interact 1982; 42: 165–177
   PubMed Web of Science ®Google Scholar
• Reuther H., Wildenauer D. B., Weger N. Interactions of the Chelating Agent 2,3-Dimercaptopropane-1-sulfonate with Red Blood Cells in Vitro. II. Effects on Metalloproteins. Chemico. Biol. Interact 1982; 42: 179–194
   PubMed Web of Science ®Google Scholar
• Domingo J. L. Metal-Induced Developmental Toxicity in Mammals: A Review. J. Toxicol. Environ. Health 1994; 42: 123–141
   PubMed Web of Science ®Google Scholar
• Jones M. M., Basinger M. A. A Hypothesis for the Selection of Chelate Antidotes for Toxic Metals. Med. Hypotheses 1982; 9: 445–453
   PubMed Web of Science ®Google Scholar
• Lazareva V. I., Lazarev A. I. Spectrophotometric Determination of Ruthenium with Unithiol. Indus. Lab. USSR 1986; 51: 1075–1080
   Google Scholar
• Usatenko Y. I., Klimovich E. A., Loshkarev Y. M. Amperometric Titration of Mercury Using a Unithiol Solution. Ukrainski. Khimicheskii. Zh 1961; 27: 823–827
   Google Scholar
• O'Connor R. J., McGown E. L., Dill K., Hallowell S. F. Relative Binding Constants of Arsenical-Antidote Adducts Determined by NMR Spectroscopy. Res. Commun. Chem. Pathol. Pharmacol 1990; 69: 365–368
   PubMedGoogle Scholar
• Jones M. M. Therapeutic Chelating Agents In Metal Ions in Biological Systems, H. Siegel. Marcel Dekker, New York 1983; 16: 47–82
   Google Scholar
• Parr W. Process for Producing of 2,3-Dimercaptopropane-1-sulfonic Acid and Its Salts. US Patent. 4382 040, 1983
   Google Scholar
• Bennett D. W., Huang L., Dill K. Semiempirical Self-Consistent Field (CNDO) Calculation of Arsenical-Antidotes Adducts. Chem. Res. Toxicol 1992; 5: 5–7
   PubMed Web of Science ®Google Scholar
• Dou Y., McHugh T., Lane W. V., Rossant C. J., Loring R. H. Interactions of Dithiols with p-Aminophenyldichloroarsine and Nicotinic Acetylcholine Receptors. J. Biol. Chem 1994; 269: 20,410–20,416
   Google Scholar
• O'Connor R. J., McGown E. L., Dill K. Two-Dimensional NMR Studies of Arsenic-Sulfhydryl Adducts. Mag. Reson. Chem 1989; 27: 669–675
   Web of Science ®Google Scholar
• Campbell J. R., Clarkson T. W., Omar M. D. The Therapeutic Use of 2,3-Dimercaptopropane-1-sulfonate in Two Cases of Inorganic Mercury Poisoning. Am. J. Med. Assoc 1986; 256: 3127–3130
   PubMed Web of Science ®Google Scholar
• Chisholm J. J., Jr., Thomas D. J. Use of 2,3-Dimercaptopropane-1-sulfonate in Treatment of Lead Poisoning in Children. J. Pharmacol. Exp. Ther 1985; 235: 665–669
   PubMed Web of Science ®Google Scholar
• Kew J., Morris C., Aihie A., Fysh R., Jones S., Brooks D. Arsenic and Mercury Intoxication Due to Indian Ethnic Remedies. Br. Med. J 1993; 306: 506–507
   PubMed Web of Science ®Google Scholar
• Moore D. F., O'Callaghan C. A., Berlyne G., Ogg C. S., Davies H. A., House I. M., Henry J. A. Acute Arsenic Poisoning: Absence of Polyneuropathy After Treatment with 2,3-Dimercaptopropanesulphonate (DMPS). J. Neurol. Neurosurg. Psychiatry 1994; 57: 1133–1135
   PubMed Web of Science ®Google Scholar
• Scott A. The Retention of Arsenic in the Late Cutaneous Complications of Its Adminstration. Br. J. Dermatol 1958; 70: 195–200
   PubMed Web of Science ®Google Scholar